<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The study objective was to examine the prevalence of depressive symptoms and relationships to quality of life and demographics in the Treatment Options for Type 2 <z:mp ids='MP_0002055'>Diabetes</z:mp> in Adolescents and Youth (TODAY) study's large, ethnically diverse youth with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 704 youth with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> &lt;2 years' duration, aged 10-17 years, and BMI â‰¥85th percentile completed depressive symptoms and quality of life measures </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Some 14.8% reported clinically significant depressive symptoms, and older girls had significantly higher rates than older boys </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSIONS: Rates of significant depressive symptoms were similar to those of healthy adolescents and lower than those of teens with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Elevated depressive symptoms, particularly in older girls, suggest clinicians assess vulnerability </plain></SENT>
</text></document>